Cargando…
Pharmacokinetics, Bioavailability, and Swallowing Safety With Riluzole Oral Film
Dysphagia is highly prevalent in patients with amyotrophic lateral sclerosis (ALS). Riluzole is a US Food and Drug Administration‐approved treatment for ALS. Riluzole oral film (ROF; Exservan™) contains riluzole in a polymer‐based film matrix. The ROF is administered by placing on the tongue, where...
Autores principales: | Wymer, James, Apple, Stephen, Harrison, Antoinette, Hill, Bryan Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087659/ https://www.ncbi.nlm.nih.gov/pubmed/36168148 http://dx.doi.org/10.1002/cpdd.1168 |
Ejemplares similares
-
Bioavailability and pharmacokinetics of oral meloxicam in llamas
por: Kreuder, Amanda J, et al.
Publicado: (2012) -
Bioavailability, pharmacokinetics and safety of riociguat given as an oral suspension or crushed tablet with and without food
por: Saleh, Soundos, et al.
Publicado: (2015) -
Improved Safety, Bioavailability and Pharmacokinetics of Zidovudine through Lactoferrin Nanoparticles during Oral Administration in Rats
por: Kumar, Prashant, et al.
Publicado: (2015) -
Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent
por: Nguyen, Ashley, et al.
Publicado: (2021) -
Pharmacokinetics and bioavailability study of two ondansetron oral soluble film formulations in fasting healthy male Chinese volunteers
por: Zhu, Yubing, et al.
Publicado: (2015)